Enrich Therapeutics
Worcester
About Enrich Therapeutics
Enrich Therapeutics is a biotechnology startup focused on the development of novel single-cell isolation platform along with the critical life science applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Grant (Aug 2020)
- Website: enrichtx.com
- Phone: 203-815-0259
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/enrich-therapeutics-24776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.